Welcome to LookChem.com Sign In|Join Free

CAS

  • or

53449-14-2

Post Buying Request

53449-14-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53449-14-2 Usage

Chemical Properties

Yellow or light yellow powder

Check Digit Verification of cas no

The CAS Registry Mumber 53449-14-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,4,4 and 9 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 53449-14:
(7*5)+(6*3)+(5*4)+(4*4)+(3*9)+(2*1)+(1*4)=122
122 % 10 = 2
So 53449-14-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H4ClN3O3/c9-5-2-6-4(1-7(5)12(14)15)8(13)11-3-10-6/h1-3H,(H,10,11,13)

53449-14-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (757004)  7-Chloro-6-nitro-4(3H)quinazolinone  97%

  • 53449-14-2

  • 757004-5G

  • 506.61CNY

  • Detail
  • Aldrich

  • (757004)  7-Chloro-6-nitro-4(3H)quinazolinone  97%

  • 53449-14-2

  • 757004-25G

  • 1,689.48CNY

  • Detail

53449-14-2Relevant articles and documents

Synthesis of alkylamino quinazolines and anti-tumor activity thereof

-

Paragraph 0060-0062; 0064, (2021/09/08)

The present invention provides a compound represented by formula (I), or a pharmaceutically acceptable salt, or ester, or prodrug thereof. The invention further provides a compound represented by the formula (I) or a pharmaceutically acceptable salt or ester, or a synthetic method of the prodrug and an application of the compound in preparation of a medicament for treating tumors.

Tetrahydroisoquinoline derivatives preparation and application of (by machine translation)

-

Paragraph 0133; 0134; 0135, (2018/09/21)

The invention mainly relates to a series of containing tetrahydroisoquinoline structure the synthesis of the compounds and in the medical field of application. Specifically, the invention relates to a series of tetrahydroisoquinoline structure compound, it can inhibit the polymerization of A β, antagonizing A β O in combination and in nerve cells caused by the cytotoxic, therapeutic or improve AD has application prospect. (by machine translation)

Artemisin derivative and its preparation and use

-

Paragraph 0303; 0304; 0307, (2016/10/08)

Provided are artemisinin derivatives of formula (I) or pharmaceutically acceptable salts thereof, or enantiomers, diastereomers, and racemic bodies thereof, and a pharmaceutical composition of the compounds, the preparation process and uses thereof. Artemisinin derivatives of formula (I) have excellent effects in the treatment of tumours.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 53449-14-2